Isryl-M2 Tablet SR: A Combined Therapy for Blood Sugar Management

Isryl-M2 Tablet SR is a once-daily, sustained-release formulation containing Glimepiride (2mg) and Metformin (500mg). This combination is used to effectively manage Type 2 Diabetes Mellitus by lowering blood sugar levels.

Glimepiride works by stimulating the release of insulin from the pancreas, helping glucose enter cells for energy production. Metformin further reduces glucose production in the liver and improves cellular sensitivity to insulin.

Isryl-M2 offers convenient sustained-release technology, ensuring consistent blood sugar control throughout the day. The combined action of Glimepiride and Metformin makes Isryl-M2 a reliable option for patients with Type 2 Diabetes seeking a safe and effective treatment solution.

Before starting any new medication, consult your healthcare provider. This prescription medication is not suitable for pregnant or breastfeeding women or individuals with certain medical conditions.

Note: This description is intended for informational purposes only and does not constitute professional medical advice. Always follow the directions of your physician or pharmacist regarding the use of this medication.